The investment in the company’s Louisville, Kentucky unit will include the purchase of a new fermenter that will start operating in the first semester of 2019.
“The expansion project was elaborated with due care in order to reduce set-up in fermentation and to optimize the use of other industrial assets, therefore, increasing our production capacity of the Bioenhance line,” said César Martins, Biorigin’s Global Operations Manager.
According to the company, this is the third expansion since its foundation 15 years ago, totaling investments of around US$ 200 million.
“These expansion initiatives were stimulated by the positive perspectives of the market, as well as by the trends related to health and well-being, which lead to an increasing search for natural ingredients, clean label, Non GMO,” added Mario Steinmetz, Biorigin’s General Manager.
